ANNEX PUBLISHERS

Journal of Pharmaceutics & Drug Development

Editorial Board Member - JPDD

Michael P. Namaka

Associate Professor
Faculty of Pharmacy and Medicine
University of Manitoba
Canada
BIOGRAPHY:

Michael Namaka is an Associate Professor in the Faculty of Pharmacy and Medicine at the University of Manitoba. In this capacity he functions as clinician/scientist specialized in multiple sclerosis & chronic neuropathic pain. This dual capacity has allowed Michael to bridge his neuroscience research to clinical practice. Currently, Michael has a clinical practice in the department of rehab medicine (Rehab Medicine Clinic) with Dr Karen Ethans as well as in the department of anesthesia (Pain Clinic) with Dr. Howard Intrater. Since his Faculty appointment, Michael has held several research grants and has published 31 manuscripts, 2 book chapters, 1 editorial letter, 42 abstracts, 12 non-peer-reviewed papers and has performed an excess of 100 invited presentations world-wide. Michael’s lifelong commitment to the profession of pharmacy is indicative by his previously help elected positions in the Association of Faculties of Pharmacy of Canada (AFPC) where he functioned in the capacities of: councilor, research chair, president elect, president and past president. Furthermore, in 2006, Michael was officially recognized as the first MS Medical Clinical Assistant dually licensed with the Manitoba Pharmaceutical Association and the College of Physicians and Surgeons of Manitoba. In this capacity Michael was one of the first pharmacists in the province of Manitoba to prescribe MS medications for the patients that he served. As a result of his new professional designation, Michael the recipient of the national commitment to care award which recognized his innovative clinical pharmacy practice in multiple sclerosis. Currently, Michael heads a cellular neuroscience research team of graduate and undergraduate summer students whose primary focus is on cytokine/neurotrophin interactions and their implications on remyelination and myelin repair. Michael also heads the gene research training institute for endMS (Manitoba/Ontario divisions) society where he serves as on senior faculty.



RESEARCH INTERESTS:

Multiple sclerosis, neuroimmunology, dorsal root ganglia, neuropathic pain, inflammatory cytokines (TNFα), neurotrophins, BDNF, NGF, experimental autoimmune encephalomyelitis (EAE), myelin repair, spinal cord, non-traumatic spinal cord injury, MeCP2, oligodendrocytes, central nervous system, myelin proteins, white matter.





Other Editorial Board Members - JPDD

BADER MUBARAK W. AL-JAEID

Faculty of Pharmacy
King Abdulaziz University
Saudi Arabia

SUNLIANG CUI

Professor
College of Pharmaceutical Sciences
Zhejiang University
China

Sherif Wagih Mansour

Professor
Department of Biomedical Sciences
King Faisal University
Saudi Arabia

Remigius U Agu

Associate Professor
Faculty of Pharmaceutical Sciences
University of Kentucky
United States

Natasa Skalko-Basnet

Professor
Department of Pharmacy
University of Tromso
Norway

James David Adams

Associate Professor
Department of Pharmacology and Pharmaceutical Sciences
University of Southern California
United States

Miroslav Pohanka

Associate Professor
Faculty of Military Health Sciences
University of Defence
Czech Republic

Petr Pavek

Associate Professor
Department of Pharmacology and Toxicology and Centre for Drug Development
Charles University in Prague
Hradec Kralove
Czech Republic

SHAUKAT ALI

Technical Support Manager
BASF Corporation
Pharma Solutions
United States

Emmanuel Ho

Assistant Professor
Department of Immunology
University of Manitoba
Canada
Submit Manuscript


Open Access Journals

View All Journals